baber/WOPTO huggingface dataset:
Patent IL-96208-A0 (IL)
Title: Apparatus and method for propagating,growing and handling plants
IPC: A01G9/06
Filed: 1990-11-01
Abstract: There is provided an apparatus and method for propagating, growing and handling plants. A tray (10) is provided having a plurality of spaced apart elongated containers (12) which are removably attached to one another. Each container has a plurality of planting compartments (42) with adjacent planting compartments being separated by an air compartment (44) each having an elongated opening which permits the movement of air into the root system of a plant located in an adjacent compartment. The air compartments also provide for vertical airflow to the leafy parts of the plants. The elongated containers are readily separated from one another and reassembled using automated apparatus. The automated apparatus removes the plants from the container for grading, transplanting and/or packaging.
Patent IL-96880-A0 (IL)
Title: Purification of human interleukin-4 from a secreted escherichia coli mutant
IPC: C07K14/52
Filed: 1991-01-04
Abstract: Active recombinant human IL-4 is purified from a crude fermentation broth of a secreted E. coli mutant by subjecting said solution to selective chromatogrphy on a zinc-chelating agarose column at pH 7.2 in a buffer containing a high concentration of sodium chloride, i.e., about 1M sodium chloride, washing first with a phosphate buffer at pH 7.2 containing 1.0M sodium chloride then with a buffer containing 10% glycerol and eluting at pH 5.0. The resulting purified active recombinant human IL-4 solution is further treated by cation exchange chromatography, concentration by diafiltration up to 20 mg/mL and size exclusion gel chromatography using a citrate buffer at pH 4.5.
Patent AU-PM506894-A0 (AU)
Title: Novel electrochemical cells
IPC: G01N27/30
Filed: 1994-04-14
Abstract: An electrochemical cell comprises a porous membrane (8) of electrically insulating composition, the membrane having pores (not illustrated) communicating from one side of the membrane to another, a working electrode (5) disposed on one side and a counter or pseudo-reference electrode (7) disposed on the other side. A target area (11) of one electrode is liquid permeable and extends over the surface of membrane (8) without blocking underlying pores of the membrane. Optional insulating layers (9, 10) cover the electrodes (5, 7) and an opening defines the target area (11). Preferably, the porous membrane is impregnated with reagents, for example GOD/Ferricyanide. <IMAGE>
Patent AU-PN442295-A0 (AU)
Title: Regulated autocrine growth of mammalian cells
IPC: C12N15/63
Filed: 1995-07-26
Abstract: Methods of production of desired recombinant proteins, polypeptides and peptides are disclosed which utilize mammalian host cells engineered for autonomous and regulated growth in low cost protein/serum-free culture media. Preferred host cells express insulin or an insulin-like growth factor, and/or transferrin and are engineered so that addition of an inducer (e.g., ZnCl2+CdCl2) halts growth and simultaneously induces the expression of the desired recombinant protein, polypeptide or peptide.
Patent FI-20045081-A0 (FI)
Inventor: KACKUR JOHNNY
IPC: B63J99/00
Filed: 2004-03-17
Abstract: Gas supply arrangement of a marine vessel being adapted to carry liquefied gas in its gas tank having an ullage space section and a liquid phase section, which arrangement provides the gas for demands of the vessel, the arrangement comprising a gas supply line provided for delivering the gas formed in the gas tank to a consumption device, and a piping extending from the liquid phase section to the ullage space section of the gas tank being provided with at least a pump, for introducing gas into the ullage space section. The piping is provided with a heat transfer unit for effecting on the temperature of the introduced gas. The invention relates also to method of providing gas in a marine vessel with liquefied gas tank.
Patent FI-20045083-A0 (FI)
Inventor: HAELLI RAMI
IPC: H04M3/523
Filed: 2004-03-18
Abstract: A method for transmitting phone calls from a phone exchange (PBX) to one or more extensions (P, MP), at least one of which extensions is a mobile phone subscription (MP), where the phone call coming from the phone exchange is signalled to via a mobile phone exchange (MCX). The phone call signalled from the phone exchange (PBX) is identified as an exchange call in the mobile phone exchange (MCX), where the settings of an exchange call are used for said phone call. In addition, the invention relates to a mobile phone exchange and a phone exchange implementing the method.
Patent FI-20115173-A0 (FI)
Inventor: SUOMINEN ARI
IPC: B63H/
Filed: 2011-02-23
Abstract: A scrubber system for treating exhaust gas in a marine vessel with a water based solution includes a first scrubber unit and a second scrubber unit, an exhaust gas inlet in the first scrubber unit and an exhaust gas outlet in the second scrubber unit and a second conduit section connecting the first scrubber unit to the second scrubber unit, a first scrubbing medium circuit and a second scrubbing medium circuit. The first scrubber medium circuit is provided with a source of scrubbing solution having a first connection to an outside of a hull of the vessel beneath the water line of the vessel and the second scrubber medium circuit is provided with a source of scrubbing solution having a source of fresh water in the vessel.
Patent IL-101818-A0 (IL)
Title: Therapeutic agent
IPC: C07C57/30
Filed: 1992-05-10
Abstract: The use of S(-)sodium 2-(4-isobutylphenyl)-propionate (the sodium salt of S(+)-ibuprofen) in pharmaceutical compositions for the treatment of inflammation, pain and pyrexia is described. Preferred compositions comprise S(-)sodium 2-(4-isobutylphenyl)-propionate dihydrate.Processes to prepare S(-)sodium 2-(4-isobutylphenyl)propionate and its use in a process to prepare S(+) 2-(4-isobutylphenyl)propionic acid of high enantiomeric purity are also described.
Patent IL-105757-A0 (IL)
Title: Protein c derivatives
IPC: C07K14/745
Filed: 1993-05-20
Abstract: Human protein C derivatives with high activity and reduced dependence on thrombin activation are described. These derivatives differ from the native forms of human protein C in their increased activation rates, functional activities and carbohydrate structures. DNA compounds, transfer vectors, expression vectors and transformants useful in producing these derivatives are also described.
Patent IL-108283-A0 (IL)
Title: Use of riluzole for promoting restoration following radiation
IPC: A61K9/48
Filed: 1994-01-06
Abstract: PCT No. PCT/FR94/00002 Sec. 371 Date Jun. 6, 1995 Sec. 102(e) Date Jun. 6, 1995 PCT Filed Jan. 3, 1994 PCT Pub. No. WO94/15600 PCT Pub. Date Jul. 21, 1994This invention relates to an application of riluzole or its pharmaceutically acceptable salts in the preparation of drugs having radiorestoring properties.
Patent IL-117532-A0 (IL)
Title: Production of compositions in the form of a solid solution of an active substance in a polymer matrix
IPC: B01J2/20
Filed: 1996-03-18
Abstract: PCT No. PCT/EP96/01047 Sec. 371 Date Nov. 21, 1996 Sec. 102(e) Date Nov. 21, 1996 PCT Filed Mar. 12, 1996 PCT Pub. No. WO96/29061 PCT Pub. Date Sep. 26, 1996A process for producing active substance compositions in the form of a solid solution of the active substance in a polymer matrix, which comprises melt extrusion of the active substance in nonionic form together with a polymer and a salt.
Patent IL-122243-A0 (IL)
Title: Somatostatin peptides
IPC: A61P9/00
Filed: 1996-06-28
Abstract: Somatostain analogues comprising the amino acid sequence of the formula (I): -(D/L)Trp-Lys-X1-X2, wherein X1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X2 is an alpha-amino acid having an aromatic residue on the Calpha side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala and t.-butyl-Ala, the residue Lys of said sequence corresponding to the residue Lys9 of the native somatostatin-14, in free form, in salt form or complexed with a detectable element have interesting pharmacological properties.
Patent IL-131172-A0 (IL)
Title: 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands (d4)
IPC: C07D295/06
Filed: 1998-01-29
Abstract: Disclosed are compounds of the formula: or the pharmaceutically acceptable addition salts thereof wherein: R<SUB>1 </SUB>is halogen or C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; and R<SUB>2 </SUB>and R<SUB>3 </SUB>are the same or different and represent hydrogen, halogen, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy, alkylthio, hydroxy, amino, mono(C<SUB>1</SUB>-C<SUB>4</SUB>)alkylamino, di(C<SUB>1</SUB>-C<SUB>4</SUB>)alkylamino, or R<SUB>2 </SUB>and R<SUB>3 </SUB>together represent a 4 carbon alkenylene moiety that together with the phenyl ring to which they are attached form a naphthyl moiety, which compounds are useful in the treatment of neuropsycological diseases such as schizophrenia, psychotic depression and mania.
Patent IL-132420-A0 (IL)
Title: A structural member
IPC: E04C3/09
Filed: 1998-04-30
Abstract: A roof truss comprising:   a chord (96) including a first substantially planar portion (100), the first substantially planar portion having an aperture therethrough; at least one web member (98) extending from the chord, the at least one web member having a non-planar cross section substantially along a length thereof, and having an end with a substantially planar portion (95); and a connector (97) securing the first and second substantially planar portions.   <IMAGE>
Patent IL-135712-A0 (IL)
Title: Methods for treating hypercoagulable states or acquired protein c deficiency
IPC: A61K38/00
Filed: 1998-10-14
Abstract: (A) A method is claimed for treatment of human patients with vascular occlusive and arterial thromboembolic disorders, comprising administering a dosage of 0.01 to 0.05 mg/kg/hr of activated protein C (APC). Also claimed are: (B) a unit dosage receptacle containing 5-20 mg of APC; (C) APC for use as a medicament for the treatment of vascular occlusive and arterial thromboembolic disorders at a dose of 0.01 to 0.05 mg/kg/hr.
Patent IL-138767-A0 (IL)
Title: Anticancer compositions
IPC: A61K9/107
Filed: 1999-03-30
Abstract: Pharmaceutical dosage forms for anticancer drugs, and paclitaxel in particular, are described in which the active drug is formulated as storage stable self-emulsifying preconcentrate.
Patent IL-148316-A0 (IL)
Title: Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent
IPC: B01J13/08
Filed: 2000-08-25
Abstract: The invention concerns a method for microencapsulation of an active principle by coacervation which consists in controlled desolvation or coacervation of a polymer dissolved in an organic solvent containing said active principle, said coacervation being induced by adding a non-solvent causing the polymer to be deposited at the surface of the active principle, and by hardening the polymer deposit by adding a hardening agent, said hardening being leading to the formation of a continuous film coating the active principle. The invention is characterised in that the solvent is selected among ethyl acetate, N-methylpyrrolidone, methylethylacetone and acetic acid. The non-solvent is advantageously an alcohol comprising two to five carbon atoms and the hardening agent being for instance selected among water, alcohols comprising four carbon atoms and mixtures thereof.
Patent IL-156549-A0 (IL)
Title: Method and composition for the treatment of diabetic neuropathy
IPC: A61K31/355
Filed: 2001-12-19
Abstract: Compositions and a method for the treatment of diabetic neuropathy are disclosed. The compositions comprise a mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant, optionally formulated in a pharmaceutically acceptable carrier. This combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In addition, the compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment. In a second aspect, a method for the administration of a composition in accordance with the present invention for the treatment of diabetic neuropathy is disclosed. In the method, an effective amount of the composition of the invention is administered over a period of time sufficient to provide the beneficial effects of relief from the symptoms of diabetic neuropathy, as well as at least some recovery of the damaged nerve tissues.
Patent IL-160075-A0 (IL)
Title: Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
IPC: A61P19/02
Filed: 2002-07-26
Abstract: The use of derivatives of hydroxamic acid having histone deacetylase enzyme-inhibiting activity for the preparation of anti-inflammatory medicaments is disclosed.
Patent IL-161738-A0 (IL)
Title: Fitting system
IPC: E05D5/02
Filed: 2002-11-05
Abstract: The invention relates to a fitting system according to parent application DE 101 19 987.3 for rotatably bearing a door leaf ( 2 ) in a glass construction. A fitting ( 1 ) is disposed on the top and/or at the bottom of said door leaf ( 2 ) and interacts with a complementary counter-fitting. A bearing axis extends in the plane of the door leaf and every fitting ( 1 ) is subdivided longitudinally by an intermediate space ( 3 ), while forming opposite bearing surfaces ( 7, 8 ), into at least partially spaced-apart fitting elements ( 4, 5 ) that can be disposed in a form-fit in a recess ( 9 ) of the door leaf ( 2 ). In order to stabilize the fitting system and to provide tamper-proof and protected fittings ( 1 ) that are also optically appealing, the fitting elements ( 4, 5 ) are fastened to the door leaf ( 2 ) by means of pins ( 16, 17 ) that are introduced at an angle to the longitudinal direction in through bores ( 14, 15 ) and in blind bores ( 12, 13 ) of the two fitting elements ( 4,5 ), while reducing the intermediate space ( 3 ). A rod stud ( 27 ) fastened to the one fitting elements ( 5 ) accommodates the two insertable pins ( 16, 17 ) while capping them, said rod stud ( 27 ) extending in parallel to the plane of the door leaf.
Patent IL-162676-A0 (IL)
Title: Process for manufacturing high density boron carbide
IPC: C01B31/36
Filed: 2004-06-22
Abstract: A process for manufacturing high density boron carbide by pressureless sintering, enabling to create sintered products of complex shapes and high strength. The process comprises mixing raw boron carbide powder with carbon precursor, such as a polysaccharide, compacting the mixture to create an object of the desired shape, and finally carbonizing and sintering the object at higher temperatures.
Patent IL-187977-A0 (IL)
Title: Methods for synthesis of encoded libraries
Filed: 2007-12-06
Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotides tag.
Patent IL-192200-A0 (IL)
Title: Method and kit for immuno-detecting bacteria in blood and tissues
IPC: G01N33/569
Filed: 2008-06-15
Abstract: The invention provides methods for screening for the presence of a clinically relevant amount of bacteria in donor blood or a blood product from a donor mammal, particularly blood or a blood product that will be transferred from the donor mammal to a recipient mammal. The method comprises contacting a sample of the donor blood or a blood product with a set of binding agents that comprises binding agents that specifically bind to Gram-negative bacterial antigen and/or binding agents that specifically bind to Gram-positive bacterial antigen, and determining binding of the set of binding agents to the sample, wherein binding indicates the presence of a clinically relevant amount of Gram-positive bacteria and/or Gram-negative bacteria in the donor blood or blood product and no binding indicates the absence of a clinically relevant amount of Gram-positive bacteria and/or Gram-negative bacteria in the donor blood or blood product. The invention further provides methods and kits for screening for the presence of a clinically relevant amount of Gram-positive bacteria, Gram-negative bacteria, or both Gram-positive and Gram-negative bacteria in a donor tissue by screening the fluid in which the donor tissue is stored.
Patent RO-125610-A0 (RO)
Title: System for dummy joints for road bridges with wide movements
Inventor: COVĂTARU CORNELIU CEZAR
IPC: E01C11/02
Filed: 2010-02-12
Abstract: The invention relates to a system for covering the dummy joints, meant especially for road bridges with wide displacements. According to the invention, the system comprises some rectangular spars (1 and 2) symmetrically placed, supported at one end reciprocally, by telescopic joining, and at the other end, being supported by means of some spherical articulations (4 and 15), to some frames (5 and 6) anchored at the structure of a bridge by means of some tie-rods (7) or by loop anchors (8), the hydro-insulation being provided by means of a drain channel (10).
Patent RO-127731-A0 (RO)
Title: Process for testing viability of lactic bacteria during the transit in human alimentary tract
Inventor: VAMANU EMANUEL
IPC: A61K49/00
Filed: 2011-11-17
Abstract: The invention relates to a process for testing the viability of certain strains of lactic bacteria producing exopolysaccharides in lyophilized form by using a system of in-vitro simulation of alimentary tract under sterility and anaerobiosis conditions in Duran tubes provided with a silicone septum which simulate the conditions in Hungate tubes. The process claimed by the invention includes the carrying out of gastric and intestinal juice, sterilization by filtration with Millipore filter upon introduction into the sterile Duran tube, determining viability under the compartment-specific simulated gastric-intestinal conditions, according to the physiologic dynamics of the transit through each compartment and computing in vitro viability and mortality, the results being read and interpreted in a completely automatic manner, using colonyQuant and the corresponding software, within 48 h, at the most, since the colonies development on the specific medium.
Patent RO-127385-A0 (RO)
Title: Compliant minigripper with piezoelectric actuator
Inventor: NOVEANU SIMONA
IPC: B25B9/02
Filed: 2011-12-08
Abstract: The invention relates to a compliant minigripper () with piezoelectric actuator () meant for the precise manipulation of various size objects, in applications specific to fine mechanics. According to the invention, the minigripper () is conceived as a monoblock structure, with some flexible couples () obtained by thinning the section of some symmetrically arranged kinematic elements () in the structure, the compliant minigripper body () containing ten flexible couples () which transmit the movement and the force, by the elastic deformation of the material they are made of, by means of the kinematic elements (), at the outlet of the piezoelectric actuator (), to some fastening elements () which carry out the manipulation, by modifying the geometric shape of the flexible couples () (elliptical, rectangular, parabolic, circular or rectangular with various transition radii), selecting the material that the compliant minigripper () is made of (steel, brass, polymethylmethacrylate, polytetrafluoroethylene etc.) as well as by the variation of the supply voltage of the piezoelectric actuator (), there being ensured a wider range of dimensions of the objects to be manipulated as well as the use thereof in various media.
Patent RO-127936-A0 (RO)
Title: Nutritional supplement for feeding pigs
Inventor: HABEANU MIHAELA
IPC: A23K1/18
Filed: 2012-03-22
Abstract: The invention relates to a nutritional supplement for feeding pigs, preferably in the fattening-finishing period. According to the invention, the supplement comprises 27...29% peas, 25...27% soya grit, 28...29% rape grit, 7...9% camelina oil, 2.7...2.9% mono-calcium phosphate, 4...4.7% calcium carbonate, 0.2% salt, 0.25...0.30% synthetic lysine, 0.2% choline premix with 60% active substance on maize carrier, 2.8% vitamin-mineral premix containing vitamin A, D3, E, K3, B1, B2, B3, B5, B6, B7, B9, B12 and the micro elements Mn, Fe, Cu, Zn, I, Se, Co, the amounts being expressed as percentage per 100 kg of nutritional supplement.
Patent IE-910133-A1 (IE)
Title: Boronic acid adducts of rhenium dioxime and technetium-99m¹dioxime complexes containing a biochemically active group
IPC: C07F5/02
Filed: 1991-01-16
Abstract: Boronic acid adducts of technetium-99m and radioactive rhenium dioxime complexes, each of which include biochemically active groups, are useful as diagnostic and therapeutic agents, respectively.
Patent LU-82654-A1 (LU)
Inventor: MAILLIET P
IPC: F16J15/50
Filed: 1980-07-24
Abstract: 1. Tight joint of an oscillating piece (4) in a support (20), the said piece (4) having a peripheral surface (24) of spherical shape cooperating with the internal surface, of corresponding spherical shape (34), of a tight packing (26) integral with the said support (20), the latter being mounted in a wall (6) separating two media at different pressures, characterized by the fact that the said support (20) includes at least partially a cylindrical section on the internal surface of which is provided the said tight packing (26) and on the external surface of which are provided, in diametrically opposite positions, two journals (16, 18) cooperating with two lateral branches (8, 10) integral with the said piece (4).
Patent LU-86347-A1 (LU)
Inventor: GERARD LANG
IPC: A61Q1/02
Filed: 1986-03-06
Abstract: Cosmetic composition designed to impart to the skin a coloring which is substantially similar to the pigmentation resulting from natural tanning, characterized in that it contains, in a cosmetically acceptable medium suitable for topical application, at least one compound of the formula:   <IMAGE> (I)  in which R1 denotes a hydrogen atom, a lower alkyl group or a residue -SiR9R10R11, R2 and R3, which may be identical or different, denote a hydrogen atom, a lower alkyl group, a carboxyl group, a lower alkoxycarbonyl group or a group -COOSiR9R10R11; R4 and R5 which may be identical or different, denote a hydrogen atom, a linear or branched C1-C20 alkyl group, a formyl group, a linear or branched C2-C20 acyl group, a linear or branched C3-C20 alkenoyl group, a group R6OSO2-, a group -SiR9R10R11, a group -P(O)(OR6)2 or an aralkyl group, or alternatively R4 and R5, with the oxygen atoms to which they are attached, form a ring optionally containing a carbonyl group when at least one of the groups, R1, R2 or R3 is other than hydrogen or alternatively a thiocarbonyl group, a residue >P(O)OR6, a group >CR7R8 or a methylene group, R6 denoting a hydrogen atom or a lower alkyl group, R7 denoting a hydrogen atom or a lower alkyl group, R8 denoting a lower alkoxy group or a mono- or dialkylamino group and R9, R10 or R11, which may be identical or different, denoting linear or branched lower alkyl groups, at least one of the substituents R1, R2, R3, R4 and R5 being other than hydrogen; and the corresponding salts with alkali metals, alkaline earth metals, ammonium or amines.
Patent MA-27999-A1 (MA)
Title: Inhibiteurs de caspases contenant un cycle isoxazolinique
Inventor: CHANG HYE-KYUNG
IPC: C07D413/04
Filed: 2006-02-17
Abstract: La présente invention concerne un dérivé isoxazolinique constituant un inhibiteur de diverses caspases, un procédé de préparation de ce dérivé et une composition thérapeutique destinée à prévenir l'inflammation et l'apoptose, cette composition comprenant ledit dérivé.